Insider · CIK 0001191905
Amit Kumar
Files at ANIX (Anixa Biosciences Inc). First filing Jan 15, 2025, latest Sep 28, 2026.
Amit Kumar files SEC Form 4 as CEO and director at ANIX (Anixa Biosciences Inc). Since Jan 15, 2025, Amit Kumar has reported 8 open-market buys worth $250k and 0 open-market sells worth $0, the latest filed on Sep 28, 2026.
A track record needs three past buys with six months of prices behind them; Amit Kumar has 0, so none is measured yet.
The newest scored trade: bought $19k of ANIX on Sep 24, 2026, filed Sep 28, 2026, scored 45 (moderate). In the last 12 months: 4 buys worth $94k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ANIX: Anixa Biosciences Inc
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | Anixa Biosciences Inc | $19k 7,000 shares | +1% | - | |
| 35Weak | Anixa Biosciences Inc | $8,250 3,000 shares | +0% | - | |
| 35Weak | Anixa Biosciences Inc | $14k 5,000 shares | +1% | - | |
| 58Moderate | Anixa Biosciences Inc | $53k 21,000 shares | +3% | +5% from low-53% from high | |
| 44Moderate | Anixa Biosciences Inc | $16k 5,000 shares | +1% | +48% from low-20% from high | |
| 44Moderate | Anixa Biosciences Inc | $16k 5,000 shares | +1% | +47% from low-21% from high | |
| 34Weak | ANIXbuy Anixa Biosciences Inc | $29k 10,000 shares | +2% | +31% from low-30% from high | |
| 53Moderate | Anixa Biosciences Inc | $96k 43,000 shares | +8% | - |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +7,000 | $2.78 | $19k | 672,000 | 15 d ago |
| Sep 10, 2026 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +3,000 | $2.75 | $8,250 | 665,000 | 29 d ago |
| Sep 10, 2026 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +5,000 | $2.76 | $14k | 662,000 | 32 d ago |
| Jun 12, 2026 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +21,000 | $2.50 | $53k | 630,812 | Jun 16, 2026 |
| Jan 5, 2026 | ANIX Anixa Biosciences Inc | AGrant or award Employee Stock Optionderivative | +350,000 | $0.00 | $0 | 350,000 | Jan 6, 2026 |
| Oct 30, 2025 | ANIX Anixa Biosciences Inc | MOption exercise Common Stock | +200,000 | $2.92 | $584k | 779,925 | Oct 31, 2025 |
| Oct 30, 2025 | ANIX Anixa Biosciences Inc | FTax withholding Common Stock | -169,439 | $4.06 | $688k | 610,486 | Oct 31, 2025 |
| Oct 30, 2025 | ANIX Anixa Biosciences Inc | MOption exercise Employee Stock Option (Right to Buy)derivative | -200,000 | $0.00 | $0 | 0 | Oct 31, 2025 |
| Jul 30, 2025 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +5,000 | $3.16 | $16k | 579,925 | Jul 31, 2025 |
| Jul 11, 2025 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +5,000 | $3.15 | $16k | 574,925 | Jul 14, 2025 |
| Jun 4, 2025 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +10,000 | $2.85 | $29k | 569,925 | Jun 5, 2025 |
| Jan 15, 2025 | ANIX Anixa Biosciences Inc | POpen-market purchase Common Stock | +43,000 | $2.23 | $96k | 559,925 | Jan 15, 2025 |
| Jan 2, 2025 | ANIX Anixa Biosciences Inc | AGrant or award Employee Stock Optionderivative | +700,000 | $0.00 | $0 | 700,000 | Jan 3, 2025 |
Questions about Amit Kumar
Answered from the filings on this page, as of the latest one.
Is Amit Kumar buying or selling?
In the last 12 months Amit Kumar reported 4 open-market buys worth $94k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $19k of ANIX on Sep 24, 2026. Grants, option exercises and tax withholding are not counted.
How did Amit Kumar's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Amit Kumar has 0.
Where does Amit Kumar file Form 4?
Amit Kumar has filed Form 4 at ANIX (Anixa Biosciences Inc) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.